Ledger.Open graph →
SEC Form D · filed March 21, 2019

Nutcracker Therapeutics, Inc

Offering
$10.9M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Igor Khandros · Emeryville, CAExec · DirectorKenrick Brice Toussaint · BAYSIDE, NYExec · DirectorRobert T. Dean · Milwaukee, WIExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗